Følg
Des Richardson
Des Richardson
Alan Mackay-Sim Distinguished Chair of Cancer Cell Biology, Griffith University
Verificeret mail på griffith.edu.au - Startside
Titel
Citeret af
Citeret af
År
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13780*2021
The evolution of iron chelators for the treatment of iron overload disease and cancer
DS Kalinowski, DR Richardson
Pharmacological reviews 57 (4), 547-583, 2005
9132005
The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
DR Richardson, P Ponka
Biochimica Et Biophysica Acta (BBA)-Reviews on Biomembranes 1331 (1), 1-40, 1997
8971997
Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come
P Yingchoncharoen, DS Kalinowski, DR Richardson
Pharmacological reviews 68 (3), 701-787, 2016
7842016
Function and regulation of transferrin and ferritin.
P Ponka, C Beaumont, DR Richardson
Seminars in hematology 35 (1), 35-54, 1998
7761998
Unraveling the mysteries of serum albumin—more than just a serum protein
AM Merlot, DS Kalinowski, DR Richardson
Frontiers in physiology 5, 299, 2014
7242014
The role of iron in cell cycle progression and the proliferation of neoplastic cells
NTV Le, DR Richardson
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1603 (1), 31-46, 2002
6032002
A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics
M Whitnall, J Howard, P Ponka, DR Richardson
Proceedings of the National Academy of Sciences 103 (40), 14901-14906, 2006
5832006
Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol
DR Richardson, DJR Lane, EM Becker, MLH Huang, M Whitnall, ...
Proceedings of the National Academy of Sciences 107 (24), 10775-10782, 2010
5802010
Iron uptake and metabolism in the new millennium
LL Dunn, YS Rahmanto, DR Richardson
Trends in cell biology 17 (2), 93-100, 2007
5762007
Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors
Y Yu, DS Kalinowski, Z Kovacevic, AR Siafakas, PJ Jansson, C Stefani, ...
Journal of medicinal chemistry 52 (17), 5271-5294, 2009
4742009
Novel di-2-pyridyl–derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment
J Yuan, DB Lovejoy, DR Richardson
Blood 104 (5), 1450-1458, 2004
4532004
Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity
DR Richardson, PC Sharpe, DB Lovejoy, D Senaratne, DS Kalinowski, ...
Journal of medicinal chemistry 49 (22), 6510-6521, 2006
4422006
Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in disease
DJR Lane, AM Merlot, MLH Huang, DH Bae, PJ Jansson, S Sahni, ...
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1853 (5), 1130-1144, 2015
4222015
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents
DR Richardson, EH Tran, P Ponka
4101995
Iron trafficking in the mitochondrion: novel pathways revealed by disease
I Napier, P Ponka, DR Richardson
Blood 105 (5), 1867-1874, 2005
3622005
Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and …
NTV Le, DR Richardson
Blood 104 (9), 2967-2975, 2004
3552004
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
DR Richardson, DS Kalinowski, S Lau, PJ Jansson, DB Lovejoy
Biochimica et Biophysica Acta (BBA)-General Subjects 1790 (7), 702-717, 2009
3412009
Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and-sensitive parasites
A Walcourt, M Loyevsky, DB Lovejoy, VR Gordeuk, DR Richardson
The international journal of biochemistry & cell biology 36 (3), 401-407, 2004
3242004
Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes
DB Lovejoy, PJ Jansson, UT Brunk, J Wong, P Ponka, DR Richardson
Cancer research 71 (17), 5871-5880, 2011
3212011
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20